Investors
Delphi Diagnostics is providing the next generation of diagnostics to personalize breast cancer treatment decisions. Learn more about our company and which events we will be attending below.
Events & Conferences
Delphi participates in several industry and investor-related events throughout the year. Contact us to connect at one of these events.
Investor Overview
Contact us to learn more and receive a full copy of the investor overview
Latest News
The most recent news from Delphi Diagnostics is published in press releases, find the full list of press releases on our news page.
New Data Confirms Endocrine Activity Index® as a Predictor of Benefit from Dose-Dense Chemotherapy
Two Abstracts Highlighting the Endocrine Activity Index were Presented at the 2024 Annual Society of Clinical Oncology Meeting
Contact Us
Want to learn more about the Endocrine Activity Index (EAI) or Delphi Diagnostics?